195 related articles for article (PubMed ID: 35711462)
1. Podocalyxin Expressed in Antigen Presenting Cells Promotes Interaction With T Cells and Alters Centrosome Translocation to the Contact Site.
Amo L; Díez-García J; Tamayo-Orbegozo E; Maruri N; Larrucea S
Front Immunol; 2022; 13():835527. PubMed ID: 35711462
[TBL] [Abstract][Full Text] [Related]
2. Podocalyxin-like protein promotes gastric cancer progression through interacting with RUN and FYVE domain containing 1 protein.
Zhi Q; Chen H; Liu F; Han Y; Wan D; Xu Z; Kuang Y; Zhou J
Cancer Sci; 2019 Jan; 110(1):118-134. PubMed ID: 30407695
[TBL] [Abstract][Full Text] [Related]
3. High Podocalyxin levels promote cell viability partially through up-regulation of Annexin A2.
San IV; Prost G; Williams JA; Moss SE; Nuber UA
Biochem Biophys Res Commun; 2016 Sep; 478(2):573-9. PubMed ID: 27470587
[TBL] [Abstract][Full Text] [Related]
4. Novel roles for podocalyxin in regulating stress myelopoiesis, Rap1a, and neutrophil migration.
Li P; Karaczyn AA; McGlauflin R; Favreau-Lessard AJ; Jachimowicz E; Vary CP; Xu K; Wojchowski DM; Sathyanarayana P
Exp Hematol; 2017 Jun; 50():77-83.e6. PubMed ID: 28408238
[TBL] [Abstract][Full Text] [Related]
5. PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.
Ogasawara S; Kaneko MK; Yamada S; Honma R; Nakamura T; Saidoh N; Yanaka M; Yoshida K; Fujii Y; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Apr; 36(2):50-56. PubMed ID: 28384052
[TBL] [Abstract][Full Text] [Related]
6. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
7. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma.
Zhou Y; Zhang L; Pan H; Wang B; Yan F; Fang X; Munnee K; Tang Z
PLoS One; 2015; 10(4):e0123208. PubMed ID: 25915207
[TBL] [Abstract][Full Text] [Related]
8. Sperm‑associated antigen 9 promotes astrocytoma cell invasion through the upregulation of podocalyxin.
Jiang J; Liu Y; Fang W; Liu F
Mol Med Rep; 2014 Jul; 10(1):417-22. PubMed ID: 24788963
[TBL] [Abstract][Full Text] [Related]
9. Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function.
Román-Fernández A; Mansour MA; Kugeratski FG; Anand J; Sandilands E; Galbraith L; Rakovic K; Freckmann EC; Cumming EM; Park J; Nikolatou K; Lilla S; Shaw R; Strachan D; Mason S; Patel R; McGarry L; Katoch A; Campbell KJ; Nixon C; Miller CJ; Leung HY; Le Quesne J; Norman JC; Zanivan S; Blyth K; Bryant DM
Sci Adv; 2023 Feb; 9(5):eabq1858. PubMed ID: 36735782
[TBL] [Abstract][Full Text] [Related]
10. Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells.
Larrucea S; Butta N; Arias-Salgado EG; Alonso-Martin S; Ayuso MS; Parrilla R
Exp Cell Res; 2008 Jun; 314(10):2004-15. PubMed ID: 18456258
[TBL] [Abstract][Full Text] [Related]
11. Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin.
Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Hanazaki K; Saibara T
Cancer Sci; 2016 Oct; 107(10):1430-1442. PubMed ID: 27461278
[TBL] [Abstract][Full Text] [Related]
12. Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic gene expression in human oral squamous cell carcinoma.
Lin CW; Sun MS; Wu HC
Int J Oncol; 2014 Aug; 45(2):710-8. PubMed ID: 24821609
[TBL] [Abstract][Full Text] [Related]
13. A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts.
Suzuki H; Ohishi T; Tanaka T; Kaneko MK; Kato Y
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203331
[TBL] [Abstract][Full Text] [Related]
14. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
[TBL] [Abstract][Full Text] [Related]
15. Control of cell adhesion and migration by podocalyxin. Implication of Rac1 and Cdc42.
Fernández D; Horrillo A; Alquezar C; González-Manchón C; Parrilla R; Ayuso MS
Biochem Biophys Res Commun; 2013 Mar; 432(2):302-7. PubMed ID: 23396057
[TBL] [Abstract][Full Text] [Related]
16. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
17. PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin.
Canals Hernaez D; Hughes MR; Dean P; Bergqvist P; Samudio I; Blixt O; Wiedemeyer K; Li Y; Bond C; Cruz E; Köbel M; Gilks B; Roskelley CD; McNagny KM
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33243933
[TBL] [Abstract][Full Text] [Related]
18. Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.
Kusumoto H; Shintani Y; Kanzaki R; Kawamura T; Funaki S; Minami M; Nagatomo I; Morii E; Okumura M
Cancer Sci; 2017 Mar; 108(3):528-535. PubMed ID: 28004467
[TBL] [Abstract][Full Text] [Related]
19. Podocalyxin in Normal Tissue and Epithelial Cancer.
Le Tran N; Wang Y; Nie G
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34201212
[TBL] [Abstract][Full Text] [Related]
20. Podocalyxin-like, targeted by miR-138, promotes colorectal cancer cell proliferation, migration, invasion and EMT.
Xu Y; Pan ZG; Shu L; Li QJ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8664-8674. PubMed ID: 30575907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
